Eliminating a gold standard in childhood acute lymphoblastic leukemia?

Pediatr Blood Cancer. 2006 Sep;47(3):242-4. doi: 10.1002/pbc.20768.

Authors

Elizabeth A Raetz¹, William L Carroll

Affiliation

¹ Department of Pediatrics, Division of Pediatric Hematology/Oncology, NYU Cancer Institute, NYU School of Medicine, New York, New York 10016, USA.

PMID: 16421903
DOI: 10.1002/pbc.20768

No abstract available

MeSH terms

Humans
Neoplasm, Residual / diagnosis
Neoplasm, Residual / pathology
Neoplasm, Residual / therapy
Neoplastic Stem Cells / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
Prognosis
Secondary Prevention